EXELIXIS, INC./GENOMICA CORPORATION SC 13D

Company

EXELIXIS, INC.

Filed

November 29, 2001

Accession Number

0000891618-01-502415

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →